Lys382
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Ubiquitylation Site Page: > Lys382  -  p53 (human)

Site Information
QstsRHkkLMFktEG   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 464658

In vivo Characterization
Methods used to characterize site in vivo:
immunoprecipitation ( 4 ) , mutation of modification site ( 4 , 6 ) , western blotting ( 4 , 6 )
Disease tissue studied:
bone cancer ( 4 , 6 ) , lung cancer ( 6 ) , non-small cell lung cancer ( 6 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Treatments:
MG132 ( 6 )

Downstream Regulation
Effects of modification on p53:
intracellular localization ( 4 ) , protein degradation ( 4 , 6 )
Effects of modification on biological processes:
transcription, inhibited ( 6 )

References 

1

Thalappilly S, et al. (2011) The p53 tumor suppressor is stabilized by inhibitor of growth 1 (ING1) by blocking polyubiquitination. PLoS One 6, e21065
21731648   Curated Info

2

Marchenko ND, et al. (2010) Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-alpha3 binding. Cell Death Differ 17, 255-67
19927155   Curated Info

3

Okamoto K, Taya Y, Nakagama H (2009) Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase. FEBS Lett 583, 2710-4
19619542   Curated Info

4

Nie L, Sasaki M, Maki CG (2007) Regulation of p53 nuclear export through sequential changes in conformation and ubiquitination. J Biol Chem 282, 14616-25
17371868   Curated Info

5

Ito A, et al. (2002) MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J 21, 6236-45
12426395   Curated Info

6

Rodriguez MS, et al. (2000) Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation. Mol Cell Biol 20, 8458-67
11046142   Curated Info